pharma-dept.gov.in : Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) Scheme

Organisation : Department of Pharmaceuticals
Scheme Name : Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) Scheme
Applicable Country : India
Website : https://pharma-dept.gov.in/prip/

What is PRIP Scheme?

The Scheme for “Promotion of Research and Innovation in Pharma MedTech sector (PRIP)” has been launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, with the goal of transforming India into a global powerhouse for R&D in the Pharma MedTech sector. The scheme has a total financial outlay of Rs 5000 crores, which includes Rs 700 crores to establish Centers of Excellence (CoEs) at seven National Institutes of Pharmaceutical Education & Research (NIPERs), and Rs 4250 crores to accelerate investments in the R&D ecosystem within the sector.

Related / Similar Scheme : LSSSDC SMDI Scheme

Categories of PRIP Funding

Industry-Academia Collaboration (B-I):
** Pharma / MedTech companies in partnership with Government Institutes of National Repute
** Upto Rs 125 Cr/project or 35% of the project cost, whichever lesser
** Innovation Stages: Ideation to Commercialization and post market studies (TRL 1 to 9)

Lab to Market Transition (B-II):
** Pharma & MedTech companies
** Upto Rs 100 Cr/project or 35% of the project cost, whichever lesser
** Innovation Stages: Early-Stage Validation to Commercialization (TRL 5 to 9)

Emerging Innovators (B-III):
** MSMEs / Startups
** Upto ₹1 Cr/project
** Innovation Stages: Ideation to Proof of Concept Established (TRL 1 to 4)

PRIP Priority Areas

** New Chemical Entity, New Biological Entity & Phytopharmaceuticals
** Complex Generics & Biosimilars
** Precision Medicine
** Medical Devices
** Orphan Drugs
** Drug Development for Antimicrobial Resistance (AMR)

Process of PRIP Funding

Step-1 : Call for Applications
Step-2 : Technical Review
Step-3 : Funding Approval
Step-4 : Monitoring & Disbursement

FAQ On PRIP Scheme

Frequently Asked Questions FAQ On PRIP Scheme

What is Component A of the Scheme?
Component A focuses on establishing Centers of Excellence (CoEs) at the existing National Institutes of Pharmaceutical Education & Research (NIPERs) in seven locations. These CoEs will specialize in specific areas of Pharma and MedTech R&D

What is Component B of the Scheme?
The financial assistance under this component would be provided to promote R&D in six priority areas. The component is further divided into three different categories: B-I, B-II and B-III.

What are the ‘Priority Areas’ under component B?
Priority areas are themes within the Pharma & MedTech R&D from which the projects for funding under PRIP scheme will be invited.

There are 6 priority areas identified under the component B of the PRIP Scheme, namely:
1. New Chemical Entities, New Biological Entities and Phyto-Pharmaceuticals
2. Complex Generics and Biosimilars
3. Precision medicine
4. Medical Devices
5. Orphan Drugs
6. Drug development for antimicrobial resistance (AMR)

Who can apply for funding under component B?
Eligible applicants include pharmaceutical or MedTech companies (Proprietary Firm or Partnership Firm or Limited Liability Partnership (LLP), or a Company /Group of companies), MSMEs (as per the definition in THE GAZETTE OF INDIA notification, Ministry of micro, small and medium enterprises dated 1st June 2020), or startups registered in India. Eligibility is determined on a range of factors including based on the annual turnover of the company and the Technology Readiness Level (TRL) of the project.

Are foreign or multinational companies eligible to apply under PRIP?
Yes. The PRIP scheme supports projects from both Indian companies and subsidiaries of multinational (MNC) companies. An Indian-incorporated entity that is wholly or partly foreign- owned is eligible to apply, as long as it meets the scheme’s other criteria. (In Category B I, such companies would still need a collaboration with an Indian government research institute.)

Are section 8 companies eligible to apply under PRIP?
No. The applying entity should be either of the following types – Proprietary Firm or Partnership Firm or Limited Liability Partnership (LLP), or a Company /Group of companies

Can two or more eligible entities jointly apply for funding under PRIP scheme?
No, entities cannot jointly apply under PRIP scheme. However, for joint entity projects one of the partnering entities can apply under PRIP scheme

Can I apply as an individual or unregistered startup, and incorporate later if selected?
No – PRIP funding can only be awarded to a registered entity. The scheme is “industry-facing,” so you must have a company or startup officially registered in India to apply. You cannot apply as an individual researcher or an unincorporated team and then form a company later. If you intend to apply under Category B III, ensure your startup is registered (and obtain a DPIIT startup recognition or Udyam MSME certificate as applicable) before submitting your application

PRIP Contact

For more information, please write to us at support-prip [at] pharma-dept.gov.in